A study published in the Endocrine Journal showed some GLP-1 drugs have been linked to an increased risk of developing blood clots
These heterogeneous responses are modulated by multiple factors, including tumor classification, study methodology, treatment duration, and patient-specific parameters (Table 1)
This is when many people panic and want to stop immediately
As retatrutide drives weight loss, blood pressure often falls
The FDA logged more than 1,150 adverse events tied to compounded semaglutide and tirzepatide as of mid-2025, with roughly 10 deaths potentially connected
For comprehensive strategies, explore maintaining weight loss after tirzepatide and understand that semaglutide withdrawal is a real phenomenon that supplements alone cannot fully address